Want to see ATTO full AI Analyst Report?

Attovia Therapeutics, Inc. (ATTO) Financial Statements

12 Followers

Attovia Therapeutics, Inc. Financial Overview

Attovia Therapeutics, Inc.'s market cap is currently $950.92M. The company's EPS TTM is $; its P/E ratio is -19.91; and it has a dividend yield of 3.40%. Attovia Therapeutics, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 1.35M	$ 0.00	$ 1.45B	$ 1.41B	$ 1.71B
Gross Profit	$ 546.00K	$ -313.00K	$ 1.36B	$ 1.34B	$ 1.64B
Operating Income	$ -67.16M	$ -41.55M	$ 72.50M	$ 56.00M	$ 63.60M
EBITDA	$ -66.36M	$ -41.24M	$ 232.70M	$ 176.90M	$ 204.40M
Net Income	$ -60.63M	$ -39.80M	$ -90.20M	$ -46.80M	$ -80.70M
Balance Sheet
Cash & Short-Term Investments	$ 152.27M	$ 69.32M	$ 129.57M	$ 210.15M	$ 125.80M
Total Assets	$ 165.89M	$ 76.72M	$ 1.10B	$ 1.19B	$ 1.32B
Total Debt	$ 5.26M	$ 0.00	$ 718.28M	$ 726.58M	$ 720.61M
Net Debt	$ -34.93M	$ -30.63M	$ 589.46M	$ 517.59M	$ 595.91M
Total Liabilities	$ 15.10M	$ 14.59M	$ 1.11B	$ 1.07B	$ 1.12B
Stockholders' Equity	$ 150.79M	$ 62.13M	$ -10.19M	$ 119.09M	$ 207.02M
Cash Flow
Free Cash Flow	$ -61.51M	$ -36.81M	$ -5.80M	$ 90.00M	$ 6.30M
Operating Cash Flow	$ -59.20M	$ -35.03M	$ 42.30M	$ 128.20M	$ 46.40M
Investing Cash Flow	$ -73.45M	$ -39.80M	$ -50.50M	$ -38.20M	$ -56.00M
Financing Cash Flow	$ 142.01M	$ 82.75M	$ -58.20M	$ -300.00K	$ 5.10M

Currency in USD

Attovia Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Attovia Therapeutics, Inc. Debt to Assets

Balance Sheet >

Attovia Therapeutics, Inc. Cash Flow

Cash Flow >

Attovia Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >